Abstract
A system of seemingly unrelated regression equations is proposed for prognostic factor adjustment and subgroup analysis when comparing two groups in a cost-effectiveness analysis with censored data. Because of the induced dependent censoring on costs and quality-adjusted survival, inverse probability weighting is employed for parameter estimation. The method is illustrated with data from two recent examples using both survival time and quality-adjusted survival time as the measures of effectiveness.
2004 John Wiley & Sons, Ltd.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Amiodarone / economics
-
Anti-Arrhythmia Agents / economics
-
Canada
-
Cost-Benefit Analysis / methods*
-
Defibrillators, Implantable / economics
-
Female
-
Heart Arrest / prevention & control
-
Humans
-
Hysterectomy, Vaginal / economics
-
Laparoscopy / economics
-
Male
-
Models, Statistical*
-
Quality-Adjusted Life Years
-
Randomized Controlled Trials as Topic / economics*
-
Survival Analysis
Substances
-
Anti-Arrhythmia Agents
-
Amiodarone